By The Institut Pasteur International Covid-19 Task Force
Since January 2020, the Institut Pasteur Covid-19 Task Force and the Institut Pasteur International Network have been extremely active worldwide in responding with science to the pandemic caused by the SARS-CoV-2 coronavirus.
The joint project developed by Chris Mok’s team at the HKU-Pasteur Research Pole and by the Institut Pasteur Tunis, Tunisia, will be funded by the Covid-19 Task Force as part of the second round of projects selection.
In this framework, the project “EASI: ELISA Assays development for SARS-COV2” will focus on the development of diagnostic tools. “ELISA” is a widely established technology to detect the presence of antigens in samples.
Screening with this ELISA assay is a reliable approach for large-scale sero-epidemiological studies, which are crucial to assess infection attack rates in the population and to accurately define disease severity and herd immunity.
Scientific collaboration in times of global pandemic is crucial to capitalize on various countries and laboratories’ expertise in order to develop groundbreaking projects.
Comentarios